ITGA6 and neoplasm: To further rule out that a contaminant of TICs might be responsible for regained tumorigenecity of the marker-negative cells, we calculated what would be the percent of the total tumor cell number contributed by these contaminating cells in weeks 1–3 for the CD49f (Fig. 5B) and weeks 1–7 for CFSE sorts (Fig. S4A).